Example: Heart Attack

Search clinical trials for: Cetuximab

Total 871 results

NCT04495621

Not yet recruiting

MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)

Conditions: Metastatic Colorectal Cancer
NCT04474470

Recruiting

A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer

Conditions: Solid Tumor, Adult; Squamous Cell Carcinoma of Head and Neck; Colorectal Adenocarcinoma; Metastatic Solid Tumor; Recurrent Solid Tumor; Head and Neck Cancer
NCT04466254

Not yet recruiting

Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer

Conditions: Metastatic Colorectal Cancer
NCT04464967

Not yet recruiting

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Conditions: Advanced Solid Tumor; Metastatic Cancer; HER2-positive Breast Cancer; HER2-positive Gastric Cancer; HER-2 Protein Overexpression; Esophageal Cancer; Ovarian Cancer; Endometrium Cancer; Bladder Cancer; Pancreatic Cancer; Colorectal Cancer; Non Small Cell Lung Cancer; EGF-R Positive Non-Small Cell Lung Cancer; Head and Neck Squamous Cell Carcinoma; Triple Negative Breast Cancer; Cervical Cancer; Sarcoma
NCT04428151

Recruiting

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

Conditions: Squamous Cell Carcinoma of Head and Neck
NCT04375384

Recruiting

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Conditions: Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Squamous Cell Carcinoma; Metastatic Head-and-neck Squamous-cell Carcinoma
NCT04359199

Not yet recruiting

QUantitative Assessment of Swallowing After Radiation (QUASAR)

Conditions: Head and Neck Cancer; Dysphagia; Oropharyngeal Dysphagia; Oropharynx Cancer; Oropharynx Squamous Cell Carcinoma
NCT04349267

Recruiting

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

Conditions: Advanced Solid Tumor
NCT04285671

Not yet recruiting

Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer

Conditions: Metastatic Lung Non-Small Cell Carcinoma; Refractory Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8
NCT04282109

Recruiting

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Conditions: Recurrent Head and Neck Squamous Cell Carcinoma; Head and Neck Cancer Stage IV
NCT04278092

Recruiting

Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure

Conditions: Head and Neck Squamous Cell Carcinoma
NCT04262635

Not yet recruiting

Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer

Conditions: Colorectal Cancer
NCT04241731

Recruiting

A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer

Conditions: Colorectal Cancer
NCT04229459

Recruiting

Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.

Conditions: Esophageal Squamous Cell Carcinoma
NCT04232748

Recruiting

Change in Body Weight During Treatment of Advanced Colorectal Cancer

Conditions: Cancer, Colorectal; Chemotherapy Effect; Weight Loss; Prognosis
NCT04224415

Not yet recruiting

Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC

Conditions: Metastatic Colorectal Cancer
NCT04218136

Recruiting

Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study

Conditions: Head and Neck Cancer
NCT04189055

Recruiting

Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.

Conditions: Cancer Colorectal
NCT04165031

Active, not recruiting

A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation

Conditions: Advanced Solid Tumor; Non-Small Cell Lung Cancer; Colorectal Cancer
NCT04160416

Recruiting

mXELOXIRI Combined With Molecular Targeted Drug in mCRC

Conditions: Unresectable Metastatic Colorectal Cancer
NCT04161560

Recruiting

Cetuximab - IRDye800 Intraoperative Fluorescence Imaging in Esophagectomy of Esophageal Cancer

Conditions: Drug Safety ; Drug Specificity
NCT04151810

Not yet recruiting

Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors

Conditions: Advanced Tumors
NCT04136600

Recruiting

EGFR Monoclonal Antibody for Advanced Gastric Cancer

Conditions: Gastric Cancer; Cetuximab; Nimotuzumab
NCT04117945

Recruiting

Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

Conditions: BRAF V600E Negative; KRAS Gene Mutation Negative; Locally Advanced Unresectable Colorectal Adenocarcinoma; Metastatic Colorectal Adenocarcinoma; NRAS Gene Mutation Negative; Stage III Colorectal Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8
NCT04106362

Recruiting

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma

Conditions: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; KRAS Protein Variant; Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
NCT04091867

Recruiting

sEphB4-HSA With Cetuximab and RT in Patients With High Risk, LAHNSCC and Heavy Smoking Histories

Conditions: Squamous Cell Carcinoma of Head and Neck
NCT04065555

Not yet recruiting

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Conditions: Head and Neck Cancer
NCT04034459

Recruiting

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC

Conditions: Metastatic Colorectal Cancer
NCT04017650

Recruiting

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Conditions: BRAF NP_004324.2:p.V600E; Metastatic Colon Adenocarcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma; Metastatic Rectal Adenocarcinoma; Progressive Disease; Recurrent Colorectal Carcinoma; Stage III Colorectal Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8; Unresectable Colon Adenocarcinoma; Unresectable Rectal Adenocarcinoma
NCT04008030

Recruiting

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Patients With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

Conditions: Metastatic Colorectal Cancer
NCT03986541

Suspended

AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer

Conditions: Colorectal Cancer Stage IV
NCT03953976

Recruiting

INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy

Conditions: Head and Neck Squamous Cell Carcinoma
NCT03944941

Recruiting

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Conditions: Skin Squamous Cell Carcinoma; Metastatic Skin Cancer
NCT03944252

Active, not recruiting

Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS)

Conditions: Squamous Cell Anal Carcinoma
NCT03923881

Recruiting

MSOT Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases

Conditions: Oral Cancer; Lymph Node Metastases
NCT03923036

Not yet recruiting

Anticancer Vigilance Of Cardiac Events (AVOCETTE) in Metastatic Colorectal Cancer

Conditions: Colorectal Cancer Metastatic
NCT03914170

Completed

Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer

Conditions: Colorectal Cancer
NCT03887442

Terminated

Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy

Conditions: Head and Neck Cancer
NCT03881787

Recruiting

Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux

Conditions: Healthy Volunteers
NCT03874026

Not yet recruiting

Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients

Conditions: Colorectal Cancer; ADCC
NCT03874741

Active, not recruiting

SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma

Conditions: Head and Neck Squamous Cell Carcinoma
NCT03817567

Recruiting

Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma
NCT03808701

Not yet recruiting

Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer

Conditions: Advanced Squamous Non-small Cell Lung Cancer
NCT03803553

Recruiting

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Conditions: Metastatic Colorectal Cancer; Stage III Colorectal Cancer
NCT03785249

Recruiting

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Conditions: Advanced Cancer; Metastatic Cancer; Malignant Neoplastic Disease
NCT03783403

Recruiting

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Subjects With Advanced Solid and Hematologic Cancers

Conditions: Neoplasms
NCT03774680

Recruiting

Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer

Conditions: Colon Cancer; Colo-rectal Cancer
NCT03768375

Recruiting

Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct; Gallbladder Cancer
NCT03769311

Suspended

Cetuximab in Head and Neck Cancer Patients

Conditions: Head and Neck Cancer; Squamous Cell Carcinoma
NCT03769506

Recruiting

Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy

Conditions: Head and Neck Cancer

Search clinical trials for: Cetuximab

Recent CRA jobs

Safety Admin

Research Scientist - LCMS - Method Development

Data Analyst II – Real World Evidence

Clinical Team Manager (Local Study Manager) FSP

Senior Logistics Coordinator / Senior Sample Coordinator - Sample Management , LIMS , GMP

Associate HR Director - Business Partner

Associate Scientist - Part-time Weekends

QC Reviewer / Senior QC Reviewer - LIMS , GMP

Site Alliance Manager

Principal Clinical Database Programmer